1. Home
  2. IMNM vs MEG Comparison

IMNM vs MEG Comparison

Compare IMNM & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • MEG
  • Stock Information
  • Founded
  • IMNM 2006
  • MEG 2012
  • Country
  • IMNM United States
  • MEG United States
  • Employees
  • IMNM N/A
  • MEG N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • MEG Professional Services
  • Sector
  • IMNM Health Care
  • MEG Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • MEG Nasdaq
  • Market Cap
  • IMNM 748.3M
  • MEG 764.0M
  • IPO Year
  • IMNM 2020
  • MEG 2020
  • Fundamental
  • Price
  • IMNM $8.84
  • MEG $22.31
  • Analyst Decision
  • IMNM Strong Buy
  • MEG Buy
  • Analyst Count
  • IMNM 5
  • MEG 5
  • Target Price
  • IMNM $26.40
  • MEG $31.80
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • MEG 417.1K
  • Earning Date
  • IMNM 08-11-2025
  • MEG 08-05-2025
  • Dividend Yield
  • IMNM N/A
  • MEG N/A
  • EPS Growth
  • IMNM N/A
  • MEG N/A
  • EPS
  • IMNM N/A
  • MEG N/A
  • Revenue
  • IMNM $10,938,000.00
  • MEG $718,904,000.00
  • Revenue This Year
  • IMNM N/A
  • MEG $10.49
  • Revenue Next Year
  • IMNM $310.65
  • MEG $7.06
  • P/E Ratio
  • IMNM N/A
  • MEG N/A
  • Revenue Growth
  • IMNM N/A
  • MEG 10.92
  • 52 Week Low
  • IMNM $5.15
  • MEG $10.51
  • 52 Week High
  • IMNM $16.81
  • MEG $41.35
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 50.27
  • MEG 57.99
  • Support Level
  • IMNM $8.35
  • MEG $21.52
  • Resistance Level
  • IMNM $9.34
  • MEG $22.53
  • Average True Range (ATR)
  • IMNM 0.53
  • MEG 1.03
  • MACD
  • IMNM -0.07
  • MEG -0.19
  • Stochastic Oscillator
  • IMNM 33.97
  • MEG 51.71

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

Share on Social Networks: